Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation

Vipawee S. Chat(Keck Hospital of USC), April W. Armstrong(University of Southern California), G. Michael Lewitt(Illinois Public Health Institute), Christopher T. Ritchlin(University of Rochester Medical Center), Joel M. Gelfand(University of Pennsylvania), Stacie Bell(National Psoriasis Foundation), Abby S. Van Voorhees(Eastern Virginia Medical School), Mark Lebwohl(Icahn School of Medicine at Mount Sinai), Kristina Callis Duffin(University of Utah), Amit Garg(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Ana‐Maria Orbai(Johns Hopkins University), Dafna D. Gladman(University of Toronto), George Han(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Paul S. Yamauchi(Gold Skin Care Center), Evan Siegel(Arthritis and Rheumatism Associates), Jóhann E. Guðjónsson(A. Alfred Taubman Health Care Center), Leon Kircik(University Medical Center), George M. Martin(University of Washington), Richard G. Langley(Dalhousie University), Christoph T. Ellebrecht(University of Pennsylvania), Jason E. Hawkes(University of California, Davis), Seemal R. Desai(The University of Texas Southwestern Medical Center), Paige Kingston(University of Southern California), Kelly M. Cordoro(University of California, San Francisco), George Gondo(National Psoriasis Foundation), Wilson Liao(Emory University), Veronica Richardson(University of Pennsylvania), Sergio Schwartzman(Cornell University), Lawrence J. Green(Aesthetic Surgery Center), Soumya M. Reddy(New York University), John Koo(University of California, San Francisco), Jeffrey M Weinberg, Kevin Winthrop(Oregon Health & Science University), Elizabeth B. Wallace(University of Colorado Anschutz Medical Campus), Steven R. Feldman(Wake Forest University)
Journal of the American Academy of Dermatology
February 7, 2024
Cited by 19


Related Papers